Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
THC vs CYH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
THC vs CYH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $17.04B | $404M |
| Revenue (TTM) | $21.45B | $21.48B |
| Net Income (TTM) | $1.70B | $-88M |
| Gross Margin | 42.8% | 53.7% |
| Operating Margin | 16.1% | -39.8% |
| Forward P/E | 11.0x | 0.8x |
| Total Debt | $13.17B | $11.58B |
| Cash & Equiv. | $2.88B | $260M |
THC vs CYH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Tenet Healthcare Co… (THC) | 100 | 893.9 | +793.9% |
| Community Health Sy… (CYH) | 100 | 91.1 | -8.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: THC vs CYH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
THC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.71
- Rev growth 3.1%, EPS growth -52.6%, 3Y rev CAGR 3.6%
- 5.2% 10Y total return vs CYH's -80.7%
CYH is the clearest fit if your priority is value.
- Lower P/E (0.8x vs 11.0x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.1% revenue growth vs CYH's -1.2% | |
| Value | Lower P/E (0.8x vs 11.0x) | |
| Quality / Margins | 7.9% margin vs CYH's -0.4% | |
| Stability / Safety | Beta 0.71 vs CYH's 1.60 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +28.4% vs CYH's -1.0% | |
| Efficiency (ROA) | 5.7% ROA vs CYH's -0.7%, ROIC 13.2% vs -70.1% |
THC vs CYH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
THC vs CYH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
THC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CYH and THC operate at a comparable scale, with $21.5B and $21.5B in trailing revenue. THC is the more profitable business, keeping 7.9% of every revenue dollar as net income compared to CYH's -0.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $21.5B | $21.5B |
| EBITDAEarnings before interest/tax | $4.3B | -$7.8B |
| Net IncomeAfter-tax profit | $1.7B | -$88M |
| Free Cash FlowCash after capex | $3.3B | -$200M |
| Gross MarginGross profit ÷ Revenue | +42.8% | +53.7% |
| Operating MarginEBIT ÷ Revenue | +16.1% | -39.8% |
| Net MarginNet income ÷ Revenue | +7.9% | -0.4% |
| FCF MarginFCF ÷ Revenue | +15.6% | -0.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.8% | +2.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +87.6% | -45.2% |
Valuation Metrics
CYH leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
At 0.8x trailing earnings, CYH trades at a 94% valuation discount to THC's 12.6x P/E.
| Metric | ||
|---|---|---|
| Market CapShares × price | $17.0B | $404M |
| Enterprise ValueMkt cap + debt − cash | $27.3B | $11.7B |
| Trailing P/EPrice ÷ TTM EPS | 12.56x | 0.76x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.96x | — |
| PEG RatioP/E ÷ EPS growth rate | 0.38x | — |
| EV / EBITDAEnterprise value multiple | 6.35x | — |
| Price / SalesMarket cap ÷ Revenue | 0.80x | 0.03x |
| Price / BookPrice ÷ Book value/share | 1.97x | — |
| Price / FCFMarket cap ÷ FCF | 6.74x | 1.94x |
Profitability & Efficiency
THC leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), THC scores 7/9 vs CYH's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +19.6% | — |
| ROA (TTM)Return on assets | +5.7% | -0.7% |
| ROICReturn on invested capital | +13.2% | -70.1% |
| ROCEReturn on capital employed | +13.8% | -87.3% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | 1.47x | — |
| Net DebtTotal debt minus cash | $10.3B | $11.3B |
| Cash & Equiv.Liquid assets | $2.9B | $260M |
| Total DebtShort + long-term debt | $13.2B | $11.6B |
| Interest CoverageEBIT ÷ Interest expense | 4.28x | 4.89x |
Total Returns (Dividends Reinvested)
THC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in THC five years ago would be worth $29,737 today (with dividends reinvested), compared to $2,049 for CYH. Over the past 12 months, THC leads with a +28.4% total return vs CYH's -1.0%. The 3-year compound annual growth rate (CAGR) favors THC at 40.8% vs CYH's -6.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -2.5% | -7.4% |
| 1-Year ReturnPast 12 months | +28.4% | -1.0% |
| 3-Year ReturnCumulative with dividends | +179.1% | -17.5% |
| 5-Year ReturnCumulative with dividends | +197.4% | -79.5% |
| 10-Year ReturnCumulative with dividends | +519.3% | -80.7% |
| CAGR (3Y)Annualised 3-year return | +40.8% | -6.2% |
Risk & Volatility
THC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
THC is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than CYH's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. THC currently trades 78.7% from its 52-week high vs CYH's 64.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.71x | 1.60x |
| 52-Week HighHighest price in past year | $247.21 | $4.47 |
| 52-Week LowLowest price in past year | $146.31 | $2.38 |
| % of 52W HighCurrent price vs 52-week peak | +78.7% | +64.2% |
| RSI (14)Momentum oscillator 0–100 | 46.1 | 44.0 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 1.6M |
Analyst Outlook
CYH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates THC as "Buy" and CYH as "Hold". Consensus price targets imply 37.8% upside for THC (target: $268) vs 2.1% for CYH (target: $3).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $268.00 | $2.93 |
| # AnalystsCovering analysts | 32 | 37 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +8.4% | +0.5% |
THC leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CYH leads in 2 (Valuation Metrics, Analyst Outlook).
THC vs CYH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is THC or CYH a better buy right now?
For growth investors, Tenet Healthcare Corporation (THC) is the stronger pick with 3.
1% revenue growth year-over-year, versus -1. 2% for Community Health Systems, Inc. (CYH). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate Tenet Healthcare Corporation (THC) a "Buy" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — THC or CYH?
On trailing P/E, Community Health Systems, Inc.
(CYH) is the cheapest at 0. 8x versus Tenet Healthcare Corporation at 12. 6x.
03Which is the better long-term investment — THC or CYH?
Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +197.
4%, compared to -79. 5% for Community Health Systems, Inc. (CYH). Over 10 years, the gap is even starker: THC returned +519. 3% versus CYH's -80. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — THC or CYH?
By beta (market sensitivity over 5 years), Tenet Healthcare Corporation (THC) is the lower-risk stock at 0.
71β versus Community Health Systems, Inc. 's 1. 60β — meaning CYH is approximately 126% more volatile than THC relative to the S&P 500.
05Which is growing faster — THC or CYH?
By revenue growth (latest reported year), Tenet Healthcare Corporation (THC) is pulling ahead at 3.
1% versus -1. 2% for Community Health Systems, Inc. (CYH). On earnings-per-share growth, the picture is similar: Community Health Systems, Inc. grew EPS 196. 7% year-over-year, compared to -52. 6% for Tenet Healthcare Corporation. Over a 3-year CAGR, THC leads at 3. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — THC or CYH?
Tenet Healthcare Corporation (THC) is the more profitable company, earning 6.
6% net margin versus 4. 1% for Community Health Systems, Inc. — meaning it keeps 6. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: THC leads at 16. 1% versus -79. 4% for CYH. At the gross margin level — before operating expenses — THC leads at 82. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is THC or CYH more undervalued right now?
Analyst consensus price targets imply the most upside for THC: 37.
8% to $268. 00.
08Which pays a better dividend — THC or CYH?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is THC or CYH better for a retirement portfolio?
For long-horizon retirement investors, Tenet Healthcare Corporation (THC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
71), +519. 3% 10Y return). Community Health Systems, Inc. (CYH) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (THC: +519. 3%, CYH: -80. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between THC and CYH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.